Nuclide
News & evidence

Readout calendar

Regulatory decisions, advisory committees, expected trial readouts, and the congresses where results land. Confirmed items carry a source. Expected items are our editorial estimate from trial registrations and sponsor statements, and can slip by quarters. Below the timeline, registry changes detected by the weekly ClinicalTrials.gov snapshot wait for editorial review.

10 confirmed0 expectedRegulatory decisionAdvisory committeeExpected readoutCongressPolicy

  1. October 2026

    2026-10-17Congressconfirmed
    EANM'26, 39th Annual Congress of the European Association of Nuclear Medicine, Vienna (17 to 21 October)

    Europe's largest nuclear medicine congress, with dedicated radiopharmacy, dosimetry and theranostics tracks. European first-in-human radioligand data and the EANM guideline updates land here.

    European Association of Nuclear MedicinePeptide receptor radionuclide therapy (PRRT)Lutetium-177 radioligand therapyRadioligand dosimetry
    Source

  2. November 2026

    2026-11-04Congressconfirmed
    SNMMI Theranostics Conference 2026, Bethesda, Maryland (4 to 7 November)

    SNMMI's conference devoted to theranostics alone: dosimetry practice, alpha-emitter programmes, supply and reimbursement rather than broad nuclear medicine.

    Society of Nuclear Medicine and Molecular ImagingRadioligand therapy (beta emitters)Radioligand dosimetryLutetium-177 radioligand therapy
    Source
    2026-11-06Congressconfirmed
    65th Annual Meeting of the Korean Society of Nuclear Medicine with the 25th ARCCNM, Seoul (6 to 7 November)

    Korea's national nuclear medicine meeting, held with the Asian Regional Cooperative Council for Nuclear Medicine. Where Korean radioligand programmes (FutureChem, CellBion) report domestically before Western congresses.

    Korean Society of Nuclear MedicineFutureChemCellBion
    Source
    2026-11-19Congressconfirmed
    66th Annual Scientific Meeting of the Japanese Society of Nuclear Medicine, Himeji (19 to 21 November)

    Japan's national nuclear medicine meeting. Japanese approvals and supply questions (domestic Mo-99 production, PDRadiopharma's product line) are discussed here first.

    Japanese Society of Nuclear MedicinePDRadiopharmaNihon Medi-Physics
    Source

  3. February 2027

    2027-02-04Congressconfirmed
    SNMMI Mid-Winter Meeting 2027, San Francisco (4 to 6 February)

    The practice-side SNMMI meeting: radiopharmacy operations, dosimetry workshops, regulatory and coding sessions.

    Society of Nuclear Medicine and Molecular ImagingRadiopharmaceutical GMP and releasing a drug that decaysRadiopharmacy and cyclotron networks
    Source
    2027-02-11Congressconfirmed
    ASCO Genitourinary Cancers Symposium 2027, San Francisco (11 to 13 February)

    Where PSMA radioligand therapy trials are first presented. The abstracts are deposited as Journal of Clinical Oncology supplements and are harvested by scripts/fetch-abstracts.ts.

    Metastatic castration-resistant prostate cancerMetastatic hormone-sensitive prostate cancerLutetium-177 vipivotide tetraxetan177Lu-PSMA-I&TPSMA PET
    Source

  4. March 2027

    2027-03-11Congressconfirmed
    9th Theranostics World Congress (TWC2027), Osaka (11 to 14 March)

    Theranostics-only congress with a dedicated targeted alpha therapy track; the 2027 edition is in Japan, which makes it the main meeting point for Asian alpha-emitter programmes.

    Radioligand therapy (beta emitters)Actinium-225 PSMA agents212Pb-DOTAMTATERadioligand dosimetry
    Source

  5. April 2027

    2027-04-30Congressconfirmed
    57th Annual Scientific Meeting of the Australian and New Zealand Society of Nuclear Medicine, Gold Coast (30 April to 2 May)

    Australia and New Zealand's nuclear medicine meeting. Australian developers (Telix, Clarity) and ANSTO's isotope supply report here.

    ANSTO (Australian Nuclear Science and Technology Organisation)Clarity PharmaceuticalsTelix Pharmaceuticals
    Source

  6. June 2027

    2027-06-05Congressconfirmed
    SNMMI Annual Meeting 2027, Washington, DC (5 to 8 June)

    The largest nuclear medicine meeting in the United States: new tracers, radiochemistry, dosimetry and the year's radioligand trial updates across oncology, cardiology and neurology.

    Society of Nuclear Medicine and Molecular ImagingRadioligand therapy (beta emitters)PSMA PETPeptide receptor radionuclide therapy (PRRT)
    Source

  7. November 2027

    2027-11-11Congressconfirmed
    67th Annual Scientific Meeting of the Japanese Society of Nuclear Medicine, Omiya (11 to 13 November)

    The 2027 edition of Japan's national nuclear medicine meeting, announced on the society's English meetings page.

    Japanese Society of Nuclear Medicine
    Source

Registry changes awaiting review

snapshot 2026-10-19 vs 2026-10-12 · 42 changes in 90 days

Detected automatically by diffing weekly ClinicalTrials.gov snapshots for every product: status moves, newly posted results and moved primary completion dates. These are expected events, not confirmed ones, until an editor checks them and adds a dated calendar entry.

Missing a date? Add it to src/data/calendar.ts with a source. Expected readouts become confirmed only when a sponsor or registry gives a date.